医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2012年
10期
1945-1947
,共3页
前列腺增生/外科学%尿道/外科学%前列腺切除术/方法
前列腺增生/外科學%尿道/外科學%前列腺切除術/方法
전렬선증생/외과학%뇨도/외과학%전렬선절제술/방법
Prostatic hyperplasia/SU%urethra/SU%prostatectomy /M T
[目的]探讨经尿道前列腺等离子体切割术(PKVP)对高龄高危前列腺增生症的疗效及安全性.[方法]对66例行 PKVP 术的高龄高危前列腺增生患者的临床资料进行回顾性总结.[结果]66例手术1次性成功,手术时间55~112 min ,平均(76.8±15.5) min ;术中失血90~150 mL ,平均(115.7±15.2) mL ;术后3个月国际前列腺症状评分( IPSS)(6.6±4.3)分和生活质量评分( QOL )(2.8±0.8)分较治疗前的(27.8±4.6)分和(5.6±0.6)分显著下降( P <0.01);最大尿流率(Qmax)(13.4 ± 3.4)mL/s 较治疗前的(6.8 ± 2.4) mL/s 显著增加( P <0.01),残余尿量(PVR)(18.5 ± 3.6)mL 较术前(68.5±12.4)mL 显著减少( P <0.01);无电切综合征病例及死亡病例.[结论]PKVP 出血少、时间短、安全性高,高龄高危前列腺增生患者并非麻醉、手术的绝对禁忌.
[目的]探討經尿道前列腺等離子體切割術(PKVP)對高齡高危前列腺增生癥的療效及安全性.[方法]對66例行 PKVP 術的高齡高危前列腺增生患者的臨床資料進行迴顧性總結.[結果]66例手術1次性成功,手術時間55~112 min ,平均(76.8±15.5) min ;術中失血90~150 mL ,平均(115.7±15.2) mL ;術後3箇月國際前列腺癥狀評分( IPSS)(6.6±4.3)分和生活質量評分( QOL )(2.8±0.8)分較治療前的(27.8±4.6)分和(5.6±0.6)分顯著下降( P <0.01);最大尿流率(Qmax)(13.4 ± 3.4)mL/s 較治療前的(6.8 ± 2.4) mL/s 顯著增加( P <0.01),殘餘尿量(PVR)(18.5 ± 3.6)mL 較術前(68.5±12.4)mL 顯著減少( P <0.01);無電切綜閤徵病例及死亡病例.[結論]PKVP 齣血少、時間短、安全性高,高齡高危前列腺增生患者併非痳醉、手術的絕對禁忌.
[목적]탐토경뇨도전렬선등리자체절할술(PKVP)대고령고위전렬선증생증적료효급안전성.[방법]대66례행 PKVP 술적고령고위전렬선증생환자적림상자료진행회고성총결.[결과]66례수술1차성성공,수술시간55~112 min ,평균(76.8±15.5) min ;술중실혈90~150 mL ,평균(115.7±15.2) mL ;술후3개월국제전렬선증상평분( IPSS)(6.6±4.3)분화생활질량평분( QOL )(2.8±0.8)분교치료전적(27.8±4.6)분화(5.6±0.6)분현저하강( P <0.01);최대뇨류솔(Qmax)(13.4 ± 3.4)mL/s 교치료전적(6.8 ± 2.4) mL/s 현저증가( P <0.01),잔여뇨량(PVR)(18.5 ± 3.6)mL 교술전(68.5±12.4)mL 현저감소( P <0.01);무전절종합정병례급사망병례.[결론]PKVP 출혈소、시간단、안전성고,고령고위전렬선증생환자병비마취、수술적절대금기.
Objective] To explore the efficacy and safety of transurethral plasma kenitic vaporization of prostate(PKVP) for the treatment of senior and high risk benign prostatic hyperplasia (BPH) .[Methods] The clinical data of 66 cases of senior and high risk BPH treated by PKVP were analyzed retrospectively .[Results]All the 66 cases were treated successfully with one‐time operation .The operation time was 55 ~ 112min(aver‐age 76 .8 ± 15 .5min) .Intraoperative blood loss volume was 90 ~ 150mL(average 115 .7 ± 15 .2mL) .IPSS and QOL scores significantly decreased from 27 .8 ± 4 .6 and 5 .6 ± 0 .6 before operation to 6 .6 ± 4 .3 and 2 .8 ± 0 .8 at 3 months after operation( P < 0 .01) .Maximum urine flow rate(Qmax) significantly increased from (6 .8 ± 2 .4)mL /s to (13 .4 ± 3 .4)mL/s( P < 0 .01) .Residual urine volume(PVR) significantly reduced from (68 .5 ± 12 .4)mL to (18 .5 ± 3 .6)mL ,and there was significant difference between before and after operation ( P <0 .05) .No transurethral resection syndrome(TRUS) occurred .There was no death case .[Conclusion] PKVP has less bleeding ,short operation time and high safety .Senior and high risk patients with BPH should not be considered as the contraindication of anesthesia and operation .
